354 related articles for article (PubMed ID: 15723379)
1. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
4. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
7. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
8. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.
Issa B
J Magn Reson Imaging; 2002 Aug; 16(2):196-200. PubMed ID: 12203768
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
10. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
13. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
16. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
[TBL] [Abstract][Full Text] [Related]
17. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?
Kitajima K; Takahashi S; Ueno Y; Miyake H; Fujisawa M; Kawakami F; Sugimura K
Eur J Radiol; 2013 Aug; 82(8):1219-26. PubMed ID: 23518144
[TBL] [Abstract][Full Text] [Related]
18. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
